Humana AB (publ)
The answer first
Does Humana beat the market?
Yes, Humana has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 97% of Nordic stocks
- Quality54
- Value92
- Trend95
No. 3 of 195 in healthcare
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, it is enough that the cash Humana keeps shrinks about 14% a year for 10 years.
Max for seven days
Follow Humana with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 27 October 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Humana
Your first answer is free, no account needed.
Do you own Humana, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Humana and a few more. Free, no card.
Super Stock+51.2%In short
- Humana has risen 55.6% over the past year, including dividends.
- Overall, Humana ranks better than 97% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 72.2%. The price is 10.9% below its peak now.
What do analysts think of Humana?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 97% of Nordic stocks.
No. 3 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 118 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity2.27
- Asset turnoverSales divided by everything the company owns1.08
- Return on equityProfit divided by equity+5.5%
- Cash conversionOperating cash flow divided by profit4.43
The ranking is built on equity ratio, ROA and how steadily profit grows.
High Low price: you pay little for what the company earns and owns.
No. 9 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.0
- P/SPrice divided by sales0.3
- P/EPrice divided by earnings19.0
- P/CFPrice divided by operating cash flow4.3
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 14 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+11.8%
- 6 months+50.6%
- 9 months+51.7%
- 12 months+55.6%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Humana
10 funds we follow own Humana. The share is how much of the fund the stock makes up.
- Sweden9
- Denmark1
- PriorNilsson Evolve ASweden · PriorNilsson4.2%
- Aktiespararna Småbolag EdgeSweden · Aktiespararna3.0%
- PLUS Mikrobolag Sverige IndexSweden · PLUS2.1%
- PLUS Hälsovård Sverige IndexSweden · PLUS0.9%
- Wealth Invest SGA Globale AktDenmark · Wealth Invest0.1%
- Skandia Småbolag Sverige Exponering ASweden · Skandia0.1%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.0%
- Skandia Sverige ExponeringSweden · Skandia0.0%
From the funds' latest known holdings.
About Humana
Humana AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 11,500 employees.
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. The company operates through three segments: Sweden, Finland, and Norway. It provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day care, and special service housing; outpatient care; assisted living homes; and specially adapted housing for individuals with functional impairments. The company also offers care services and assistance to individuals with permanent functional impairments.


See the full analysis of Humana.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card